Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
03/2002
03/07/2002US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
03/07/2002US20020028813 Isoquinoline inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose) polymerase (PARP); treat tissue damage from necrosis or apoptosis, ischemia or reperfusion injury, stroke, senescence diseases
03/07/2002CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai
03/06/2002EP1184370A2 Compounds with growth hormone releasing properties
03/06/2002EP1183235A2 INHIBITORS OF FACTOR Xa
03/06/2002EP1183234A1 INHIBITORS OF FACTOR Xa
03/05/2002US6353119 Preparation of 3-substituted-4-arylquinolin-2-one derivatives
03/05/2002US6353103 Stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety.
03/05/2002US6353099 Substituted ureas as cell adhesion inhibitors
03/05/2002US6352993 Pyrimidine derivatives and processes for the preparation thereof
02/2002
02/28/2002WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
02/28/2002WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002WO2001046200A8 Novel piperidine and piperazine derivatives
02/28/2002WO2001042216A3 Caspase inhibitors and uses thereof
02/28/2002US20020025962 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/27/2002EP1182195A1 Cyclic compounds and uses thereof
02/27/2002EP1181270A2 Inhibitors of factor xa
02/27/2002EP1181267A1 Halogen compounds
02/27/2002EP1181266A1 Squaric acid derivatives as cell adhesion molecules
02/27/2002CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors
02/26/2002CA2143249C Substituted sulfonamides; process for preparing the same and pharmaceutical compositions containing them
02/21/2002WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity
02/21/2002WO2001068609B1 1,2,3,4-tetrahydroisoquinoline derivatives
02/21/2002US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
02/21/2002US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
02/21/2002US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration
02/21/2002US20020022596 Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them
02/19/2002US6348448 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
02/14/2002WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002WO2002012193A1 Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
02/14/2002WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same
02/14/2002WO2002011707A2 Drugs for incontinence
02/14/2002US20020019540 Conformationally constrained compounds as pharmaceutical agents
02/14/2002US20020019531 Indoles
02/14/2002US20020019416 Esters and amides as pla2 inhibitors
02/14/2002US20020019410 Central nervous system disorders
02/14/2002US20020019397 Heterocycle carboxamides as antiviral agents
02/14/2002CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/13/2002EP1178802A1 Cyclic amidines useful as nmda nr2b antagonists
02/13/2002EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
02/13/2002EP0861236B1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids
02/13/2002EP0594795B1 Michellamines useful as antiviral agents, composition and method of treatment
02/07/2002WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002WO2002010136A1 3-substituted isoquinolin-1-yl derivatives
02/07/2002WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
02/07/2002WO2001087843A8 Compounds for treating disorders where a decreased level of plasma ffa is desired
02/07/2002US20020016460 Pyridine -imidazole, -thiazole or -oxazole derivatives; treating autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer
02/07/2002US20020016370 A therapeutically effective amount of exo-R-mecamylamine or salt, substantially free of exo-S-mecamylamine in combination with a carrier; useful for treating substance addiction
02/07/2002US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha
02/07/2002DE10035997A1 Verwendung von anellierten Dihydropyridinen zur Herstellung von Mitteln für die Behandlung von chronischen Schmerzen Use of fused dihydropyridines for producing agents for the treatment of chronic pain
02/07/2002DE10031391A1 Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie Bicyclic compounds and their use for the prophylaxis and therapy of cerebral ischemia
02/07/2002CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002CA2417059A1 3-substituted isoquinolin-1-yl derivatives
02/06/2002EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
02/06/2002EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands
02/06/2002CN1334804A Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same
02/05/2002US6344486 Anticoagulants
02/05/2002US6344466 Antithrombotic activity, use in inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, anticoagulants
01/2002
01/31/2002WO2002008221A2 Capsaicin receptor ligands
01/31/2002WO2002008169A1 Ruthenium complexes and their use in asymmetric hydrogenation
01/31/2002WO2002007714A2 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain
01/31/2002WO2001014328A3 Substituted ureas as cell adhesion inhibitors
01/31/2002US20020013460 Condensed pyridine compound
01/31/2002US20020013352 Novel substituted diamine derivatives useful as motilin antagonists
01/31/2002US20020013333 As inhibitors of matrix metalloproteinase, for therapy of diseases such as degenerative diseases and certain cancers
01/31/2002CA2415738A1 Ruthenium complexes and their use in asymmetric hydrogenation
01/31/2002CA2415606A1 Capsaicin receptor ligands
01/30/2002CN1333769A Thiourea inhibitors of herps viruses
01/30/2002CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
01/29/2002CA2053477C Heterocyclic amine derivatives, their production and use
01/23/2002EP1174419A1 A method for producing an alpha-aminonitrile from a tertiary amine and a cyanide through oxidation with oxygen by using a transition metal catalyst
01/23/2002CN1332725A Thiourea inhibitors of herpes viruses
01/22/2002US6340760 Process for the preparation of (S)-N-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxyamide
01/22/2002US6340759 Fused pyridine derivatives
01/22/2002US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
01/17/2002WO2002004626A1 Fungal cell wall synthesis gene
01/17/2002WO2002004443A2 Heterocycle carboxamides as antiviral agents
01/17/2002WO2002004423A1 Thrombin inhibitors comprising an aminoisoquinoline group
01/17/2002WO2002004422A2 Heterocycle carboxamides as antiviral agents
01/17/2002WO2000071493A3 INHIBITORS OF FACTOR Xa
01/17/2002DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments
01/17/2002CA2415569A1 Fungal cell wall synthesis gene
01/17/2002CA2413035A1 Thrombin inhibitors comprising an aminoisoquinoline group
01/16/2002EP1172359A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-$g(a) PRODUCTION INHIBITOR
01/16/2002CN1331593A Pharmaceutical compsns. contg. tetrahydroisoquinoline compounds
01/16/2002CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors
01/10/2002WO2002002541A2 Inhibitors of copper-containing amine oxidases
01/10/2002WO2002002090A2 Inhibitors of copper-containing amine oxidases
01/10/2002WO2001034603A3 Bicyclic and tricyclic heteroaromatic compounds
01/10/2002CA2414807A1 Inhibitors of copper-containing amine oxidases
01/10/2002CA2414799A1 Inhibitors of copper-containing amine oxidases
01/08/2002CA2080140C Photodynamic plant defoliants and chlorophyll biosynthesis modulators
01/03/2002US20020002183 Benzamides and related inhibitors of factor Xa
01/02/2002EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof
01/02/2002EP1167342A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
01/02/2002EP1165545A1 Novel compounds
01/02/2002EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
01/02/2002CN1329608A Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenediamine group
01/02/2002CN1077109C S type 2-substituted hydroxy 2-indolidinylbutyric ester compounds and process for preparation thereof
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 119